Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
3.970
+0.120 (3.12%)
Oct 14, 2025, 3:45 PM EDT
Hypera Market Cap
Hypera has a market cap or net worth of $2.49 billion as of October 14, 2025. Its market cap has decreased by -17.15% in one year.
Market Cap
2.49B
Enterprise Value
3.93B
Revenue
1.22B
Ranking
n/a
PE Ratio
18.24
Stock Price
$3.97
Market Cap Chart
Since April 18, 2008, Hypera's market cap has increased from 1.59B to 2.49B, an increase of 56.60%. That is a compound annual growth rate of 2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 2.49B | 35.40% |
| Dec 30, 2024 | 1.84B | -60.72% |
| Dec 28, 2023 | 4.67B | -14.36% |
| Dec 29, 2022 | 5.46B | 70.31% |
| Dec 30, 2021 | 3.20B | -23.62% |
| Dec 30, 2020 | 4.20B | -25.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |